Skip to main content

Table 2 Eligibility criteria for RSV GOLD III—ICU Network Study

From: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol

Inclusion criteria

Group A

Group B

Age < 2 years at time of sampling;

Admitted to PICU / HDU / NICU;

Meeting WHO “Extended SARI” case definition:

Severe (defined as requiring hospitalization); and

Acute (defined as onset within the last 10 days); and

Respiratory infection (defined as having cough or shortness of breath)

In infants less than 6 months, additionally include those who present with:

Apnea (temporary cessation of breathing from any cause); and/or

Sepsis, defined as:

Fever (37.5 °C or above) or hypothermia (less than 35.5 °C); and

Shock (defined as lethargy, fast breathing, cold skin, prolonged capillary refill or fast weak pulse); and

Seriously ill with no apparent cause

Signed and dated written informed (deferred) consent obtained from the parent(s)/legal representative(s) of the subject, or in accordance with local regulations

Age < 2 years at time of sampling;

Admitted to PICU / HDU / NICU;

Signed and dated written informed (deferred) consent obtained from the parent(s)/legal representative(s) of the subject, or in accordance with local regulations

  1. PICU pediatric intensive care unit, HDU high dependency unit, NICU neonatal intensive care unit, WHO world health organization, SARI severe acute respiratory infection